VOL. XCIV, NO. 247

★ WIDE MOAT STOCKS & COMPETITIVE ADVANTAGES ★

PRICE: 0 CENTS

Monday, December 29, 2025

DSM-Firmenich AG

DSFIR · Euronext Amsterdam

Market cap (USD)
SectorMaterials
CountryCH
Data as of
Moat score
63/ 100

Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.

Request update

Spot something outdated? Send a quick note and source so we can refresh this profile.

Overview

DSM-Firmenich AG is a Swiss-incorporated ingredients company listed on Euronext Amsterdam (DSFIR) with four Business Units: Perfumery & Beauty, Taste/Texture/Health, Health/Nutrition/Care, and Animal Nutrition & Health. Across segments, the moat is built on deep customer intimacy and co-creation enabled by a large global science, creation, and application-lab footprint. Perfumery & Beauty additionally benefits from backward-integrated ingredient supply and proprietary inputs ('captives') that support differentiated perfumery palettes. In Health and Animal Nutrition, regulatory/qualification barriers and service ecosystems can create stickiness, though commodity cycles (e.g., vitamins) and regulatory shifts remain key erosion risks. Management has indicated a planned separation of Animal Nutrition & Health, which may change portfolio and moat structure over time.

Primary segment

Perfumery & Beauty

Market structure

Oligopoly

Market share

HHI:

Coverage

4 segments · 8 tags

Updated 2025-12-29

Segments

Perfumery & Beauty

B2B fragrances, perfumery ingredients, and beauty ingredients

Revenue

31%

Structure

Oligopoly

Pricing

moderate

Share

Peers

GIVN.SWSY1.DEIFF

Taste, Texture & Health

B2B food & beverage flavors and ingredient solutions (taste, texture, functional ingredients)

Revenue

25.4%

Structure

Oligopoly

Pricing

moderate

Share

Peers

GIVN.SWSY1.DEIFFKYGA.IR

Health, Nutrition & Care

Nutrition and health ingredients & solutions (dietary supplements, early life nutrition, pharma, biomedical)

Revenue

17.3%

Structure

Competitive

Pricing

moderate

Share

Peers

IFFBAS.DELONN.SW

Animal Nutrition & Health

Animal nutrition ingredients, premixes, feed additives, and precision services

Revenue

26%

Structure

Competitive

Pricing

weak

Share

Peers

EVK.DEBAS.DEADM

Moat Claims

Perfumery & Beauty

B2B fragrances, perfumery ingredients, and beauty ingredients

Revenue share computed from 2024 segment net sales (Sales EUR 3,964m; Total EUR 12,799m) in the Integrated Annual Report 2024 segment information table: https://annualreport.dsm-firmenich.com/2024/our-businesses/financial-performance.html

Oligopoly

Supply Chain Control

Supply

Strength: 4/5 · Durability: medium · Confidence: 4/5 · 1 evidence

Backwards-integrated ingredient portfolio (incl. proprietary 'captives') supports supply assurance and differentiated perfumery palettes.

Erosion risks

  • Regulatory restrictions on certain fragrance ingredients
  • Supply shocks in naturals and key chemical precursors
  • Large peers expand vertical integration or secure exclusive feedstocks

Leading indicators

  • Gross margin stability vs raw-material volatility
  • OTIF / service levels around peak demand
  • Mix shift toward proprietary ingredients and premium creations

Counterarguments

  • Large peers also have deep ingredient portfolios and vertical integration
  • Many aroma chemicals are widely available, limiting input exclusivity

Training Org Change Costs

Demand

Strength: 4/5 · Durability: medium · Confidence: 3/5 · 2 evidence

Customer-intimacy and application/creation infrastructure embeds DSM-Firmenich into customer briefs; switching typically requires re-briefing, reformulation, testing, and re-approval.

Erosion risks

  • AI-assisted formulation reduces reliance on supplier application expertise
  • Procurement-driven re-bids increase customer switching frequency
  • Growth of private label reduces willingness to pay for differentiated creations

Leading indicators

  • Major brief win-rate and renewal cadence
  • Customer retention and share-of-wallet
  • Innovation pipeline conversion to launches

Counterarguments

  • Large customers routinely multi-source and can re-tender fragrance briefs
  • Sensory equivalence work can enable switching over time

IP Choke Point

Legal

Strength: 3/5 · Durability: medium · Confidence: 3/5 · 1 evidence

Large IP portfolio and innovation spending support proprietary molecules/processes and differentiated ingredient platforms across perfumery and beauty actives.

Erosion risks

  • Patent expiry and invent-around by peers
  • Ingredient restrictions reduce monetization of proprietary molecules

Leading indicators

  • Patent filings/grants in key chemistry/biotech areas
  • Share of sales from new products / innovations
  • Adoption of proprietary ingredients in new customer launches

Counterarguments

  • Patents do not guarantee customer preference in a creative, brand-driven category
  • Trade secrets/know-how may matter more than patents in practice

Taste, Texture & Health

B2B food & beverage flavors and ingredient solutions (taste, texture, functional ingredients)

Revenue share computed from 2024 segment net sales (Sales EUR 3,245m; Total EUR 12,799m) in the Integrated Annual Report 2024 segment information table: https://annualreport.dsm-firmenich.com/2024/our-businesses/financial-performance.html

Oligopoly

Training Org Change Costs

Demand

Strength: 4/5 · Durability: medium · Confidence: 4/5 · 1 evidence

Co-creation tied to customers' specific recipes and matrices makes supplier swaps costly due to reformulation, sensory validation, and scale-up work.

Erosion risks

  • Customer insourcing of application labs and reformulation work
  • Commoditization of some flavor/ingredient components
  • Regulatory-driven recipe changes increase re-tendering frequency

Leading indicators

  • Customer retention and net revenue retention in key accounts
  • Pipeline growth from concept-selling/cross-selling
  • Time-to-commercialization for new concepts

Counterarguments

  • Large food companies have significant internal R&D and can dual-source
  • In cost-focused categories, price competition can override switching frictions

Scope Economies

Supply

Strength: 3/5 · Durability: medium · Confidence: 4/5 · 2 evidence

Broad portfolio across taste/texture/health enables concept-selling and cross-selling, improving customer coverage and lowering cost-to-serve per customer relationship.

Erosion risks

  • Portfolio complexity increases overhead and slows decision-making
  • Customers prefer best-of-breed point suppliers in niche categories

Leading indicators

  • Cross-sell rate (multi-solution penetration per customer)
  • SG&A efficiency (cost-to-serve) trend
  • Share of sales from new concepts and platforms

Counterarguments

  • Peers also offer broad portfolios; differentiation may be limited
  • Scope can dilute focus and innovation speed in fast-moving niches

Learning Curve Yield

Supply

Strength: 4/5 · Durability: durable · Confidence: 4/5 · 1 evidence

Large scientific and application footprint supports iterative formulation, scale-up learning, and faster development cycles across many food matrices and geographies.

Erosion risks

  • Talent retention challenges in high-skill R&D roles
  • Fast follower competitors narrow time-to-market gaps

Leading indicators

  • R&D productivity (launches per EUR R&D)
  • Customer adoption rates of new platforms
  • Time-to-scale for new ingredient technologies

Counterarguments

  • Innovation is not exclusive; peers have comparable R&D budgets
  • Customer purchasing may prioritize cost over technical advantage

Health, Nutrition & Care

Nutrition and health ingredients & solutions (dietary supplements, early life nutrition, pharma, biomedical)

Revenue share computed from 2024 segment net sales (Sales EUR 2,214m; Total EUR 12,799m) in the Integrated Annual Report 2024 segment information table: https://annualreport.dsm-firmenich.com/2024/our-businesses/financial-performance.html

Competitive

Compliance Advantage

Legal

Strength: 4/5 · Durability: medium · Confidence: 3/5 · 1 evidence

Regulatory approvals and quality systems can create barriers to entry and favor scaled incumbents in regulated nutrition/pharma-adjacent ingredient markets.

Erosion risks

  • Regulatory changes increase costs or restrict ingredient claims
  • Quality incidents could damage trust and increase audits

Leading indicators

  • Number/pace of new regulatory approvals and registrations
  • Audit outcomes / quality metrics (deviations, recalls)
  • Pricing/margin stability in regulated subcategories

Counterarguments

  • Many regulated ingredients still face intense competition once approved
  • Compliance can become table-stakes rather than a differentiator

Design In Qualification

Demand

Strength: 4/5 · Durability: medium · Confidence: 3/5 · 1 evidence

In early life nutrition, pharma, and biomedical materials, customers often qualify suppliers and formulations; re-qualification can be time-consuming and risky.

Erosion risks

  • Customers diversify sourcing to reduce risk
  • Standardization of ingredients reduces qualification friction

Leading indicators

  • Contract duration / renewal rates in pharma and early-life accounts
  • Share of revenue from qualified/regulated products
  • Customer complaint and audit escalation rates

Counterarguments

  • Some ingredients (e.g., commodity vitamins) are easier to switch than specialized APIs
  • Large customers can impose dual-sourcing requirements, reducing lock-in

Learning Curve Yield

Supply

Strength: 3/5 · Durability: durable · Confidence: 4/5 · 1 evidence

Scale of science and application work supports continual innovation (new formats, evidence-based solutions) that can differentiate in fast-evolving health and wellness categories.

Erosion risks

  • Clinical evidence expectations increase cost and time-to-market
  • Fast-moving D2C brands shift demand toward lower-cost suppliers

Leading indicators

  • Launch cadence of new formats/ingredients
  • Share of sales from products launched in the last 3-5 years
  • Scientific publication/clinical pipeline progress (where applicable)

Counterarguments

  • Innovation alone may not protect margins if channels commoditize
  • Peers can license or replicate similar formats and claims over time

Animal Nutrition & Health

Animal nutrition ingredients, premixes, feed additives, and precision services

Revenue share computed from 2024 segment net sales (Sales EUR 3,324m; Total EUR 12,799m) in the Integrated Annual Report 2024 segment information table: https://annualreport.dsm-firmenich.com/2024/our-businesses/financial-performance.html

Competitive

Service Field Network

Supply

Strength: 4/5 · Durability: medium · Confidence: 4/5 · 1 evidence

Combining product sales with a premix network and precision/decision-support services increases stickiness and expands the value proposition beyond ingredients alone.

Erosion risks

  • Service offerings replicated by peers and integrators
  • Farm economics downturn reduces willingness to pay for services
  • Separation/carve-out disrupts service delivery or investment

Leading indicators

  • Attach rate of services to premix/product sales
  • Retention of premix accounts
  • Digital/precision user engagement and renewal metrics

Counterarguments

  • Many customers buy largely on price and availability in down-cycles
  • Integrators may develop internal nutrition teams and tools

Ecosystem Complements

Network

Strength: 3/5 · Durability: medium · Confidence: 4/5 · 1 evidence

Partnership ecosystem around environmental footprinting can increase adoption by connecting farmers, processors, feed millers, investors, and retailers into a common workflow.

Erosion risks

  • Competing footprinting standards/platforms fragment adoption
  • Regulatory changes alter measurement/verification requirements

Leading indicators

  • Number of active partners and covered value-chain nodes
  • Customer adoption of footprinting tools (active users, projects)
  • Premium pricing or volume uplift tied to verified footprint reductions

Counterarguments

  • Ecosystem effects may be limited if partners multi-home across platforms
  • Footprinting can become commoditized as standards converge

Data Workflow Lockin

Demand

Strength: 3/5 · Durability: medium · Confidence: 3/5 · 1 evidence

Precision Services and farm-data analytics can embed DSM-Firmenich in customer decision workflows, creating switching friction beyond product-level substitution.

Erosion risks

  • Customers and integrators adopt third-party or in-house analytics platforms
  • Data interoperability standards reduce switching friction
  • Data/privacy regulation constrains data collection and monetization

Leading indicators

  • Active users and renewal rates for precision/digital services
  • Service attach rate to premix/additive sales
  • Number of strategic customer agreements tied to analytics/services

Counterarguments

  • Farm management software vendors can disintermediate ingredient suppliers
  • Analytics value may not be sufficient to overcome price-driven procurement

Evidence

other
Integrated Annual Report 2024 - Perfumery & Beauty: Our markets

broadest, backwards-integrated portfolio in the industry, with a world-class palette, including captives

Direct statement of backward integration and proprietary inputs (captives).

other
Integrated Annual Report 2024 - Our unique business model

fueled by customer intimacy

Customer intimacy is positioned as a core element of the operating model.

other
Integrated Annual Report 2024 - Science & Research

40 creation centers, and 78 application laboratories

Creation + application lab footprint supports co-creation and customer-specific formulation work.

other
Integrated Annual Report 2024 - Our drivers of success

portfolio of more than 16,000 patents

Scale of IP portfolio supports ongoing differentiated innovation.

other
Integrated Annual Report 2024 - Taste, Texture & Health: Our markets

unique ability to co-create Taste solutions with the optimal Food and Beverage matrix

Explicit claim of matrix-specific co-creation capability (a key switching-cost driver).

Showing 5 of 14 sources.

Risks & Indicators

Erosion risks

  • Regulatory restrictions on certain fragrance ingredients
  • Supply shocks in naturals and key chemical precursors
  • Large peers expand vertical integration or secure exclusive feedstocks
  • AI-assisted formulation reduces reliance on supplier application expertise
  • Procurement-driven re-bids increase customer switching frequency
  • Growth of private label reduces willingness to pay for differentiated creations

Leading indicators

  • Gross margin stability vs raw-material volatility
  • OTIF / service levels around peak demand
  • Mix shift toward proprietary ingredients and premium creations
  • Major brief win-rate and renewal cadence
  • Customer retention and share-of-wallet
  • Innovation pipeline conversion to launches
Created 2025-12-29
Updated 2025-12-29

Curation & Accuracy

This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).

Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.